These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 10487632)

  • 1. The effect of finasteride on the prostate gland in men with elevated serum prostate-specific antigen level.
    Coltman CA
    Br J Cancer; 1999 Sep; 81(1):184-5. PubMed ID: 10487632
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostate cancer prevention and finasteride.
    D'Amico AV; Barry MJ
    J Urol; 2006 Nov; 176(5):2010-2; discussion 2012-3. PubMed ID: 17070238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of prostate cancer with finasteride.
    Burke HB
    N Engl J Med; 2003 Oct; 349(16):1569-72; author reply 1569-72. PubMed ID: 14562806
    [No Abstract]   [Full Text] [Related]  

  • 4. Preventing prostate cancer. Finasteride shrinks enlarged prostates and may prevent some cases of prostate cancer. But it's no panacea.
    Beer TM
    Health News; 2003 Aug; 9(8):1-2. PubMed ID: 12971313
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term effects of finasteride on prostate specific antigen levels: results from the prostate cancer prevention trial.
    Etzioni RD; Howlader N; Shaw PA; Ankerst DP; Penson DF; Goodman PJ; Thompson IM
    J Urol; 2005 Sep; 174(3):877-81. PubMed ID: 16093979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New finasteride trial results aim to curb controversy.
    Bankhead C
    J Natl Cancer Inst; 2006 Aug; 98(16):1104-5. PubMed ID: 16912260
    [No Abstract]   [Full Text] [Related]  

  • 7. Case records of the Massachusetts General Hospital. Case 15-2008. A 55-year-old man with an elevated prostate-specific antigen level and early-stage prostate cancer.
    Barry MJ; Kaufman DS; Wu CL
    N Engl J Med; 2008 May; 358(20):2161-8. PubMed ID: 18480209
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of prostate cancer with finasteride.
    Ross RK; Skinner E; Cote RJ
    N Engl J Med; 2003 Oct; 349(16):1569-72; author reply 1569-72. PubMed ID: 14562807
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: Long-term effects of finasteride on prostate specific antigen levels: results from the Prostate Cancer Prevention Trial.
    Walsh PC
    J Urol; 2006 Jul; 176(1):409-10; author reply 410. PubMed ID: 16753454
    [No Abstract]   [Full Text] [Related]  

  • 10. Early diagnosis of prostate cancer in finasteride treated BPH patients.
    Tarle M; Kraus O; Trnski D; Reljic A; Ruzic B; Katusic J; Spajic B; Kusic Z
    Anticancer Res; 2003; 23(1B):693-6. PubMed ID: 12680169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A slippery preventive slope.
    Justman S
    Hastings Cent Rep; 2009; 39(2):49. PubMed ID: 19388386
    [No Abstract]   [Full Text] [Related]  

  • 12. Finasteride improves the sensitivity of digital rectal examination for prostate cancer detection.
    Thompson IM; Tangen CM; Goodman PJ; Lucia MS; Parnes HL; Lippman SM; Coltman CA
    J Urol; 2007 May; 177(5):1749-52. PubMed ID: 17437804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of finasteride on prostate-specific antigen.
    Nadler RB
    Lancet Oncol; 2007 Jan; 8(1):4-5. PubMed ID: 17196505
    [No Abstract]   [Full Text] [Related]  

  • 14. [Practical follow-up of a patient treated with finasteride in screening for prostate cancer].
    Villers A
    Prog Urol; 2008 Apr; 18 Suppl 3():S58-62. PubMed ID: 18455086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Undetectable prostate specific antigen at 6-12 months: a new marker for early success in hormonally treated patients after prostate brachytherapy.
    Miller N; Smolkin ME; Bissonette E; Theodorescu D
    Cancer; 2005 Jun; 103(12):2499-506. PubMed ID: 15852361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evolution of the PCPT from clinical to molecular analyses.
    Hoque A
    Nat Clin Pract Oncol; 2006 Nov; 3(11):581. PubMed ID: 17080169
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of finasteride on risk of prostate cancer: how little we really know.
    Rubin MA; Kantoff PW
    J Cell Biochem; 2004 Feb; 91(3):478-82. PubMed ID: 14755678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for prostate cancer.
    Brawley OW; Ankerst DP; Thompson IM
    CA Cancer J Clin; 2009; 59(4):264-73. PubMed ID: 19564245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of finasteride on the sensitivity of PSA for detecting prostate cancer.
    Thompson IM; Chi C; Ankerst DP; Goodman PJ; Tangen CM; Lippman SM; Lucia MS; Parnes HL; Coltman CA
    J Natl Cancer Inst; 2006 Aug; 98(16):1128-33. PubMed ID: 16912265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of hormonal levels in patients with male androgenetic alopecia treated with finasteride: better response in patients under 26 years old.
    Camacho FM; García-Hernández MJ; Fernández-Crehuet JL
    Br J Dermatol; 2008 May; 158(5):1121-4. PubMed ID: 18363752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.